|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Nov 30, 2024
|
FY2023
12 months to Nov 30, 2023
|
FY2022
12 months to Nov 30, 2022
|
FY2021
12 months to Nov 30, 2021
|
|
|---|---|---|---|---|---|
| Net Income | |||||
| Amortization expense | |||||
| Imputed interest | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Amortization | |||||
| Imputed interest | |||||
| Impairment loss on goodwill | |||||
| Impairment loss on intangible assets | |||||
| Issuance of common stock to non-affiliates for services | |||||
| Issuance of common stock to related party for services | |||||
| Gain on loan settlement | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid | |||||
| Other receivable | |||||
| Prepaid expense | |||||
| Accounts payable | |||||
| Deferred Share Issuance Cost | |||||
| Accounts payable and accrued liabilities | |||||
| Accrued Interest | |||||
| Net Cash Used in Operating Activities | |||||
| Cash Flows from Investing Activities: | |||||
| Net funds from acquisition of Xirangsheng (Shenzhen) Health Technology Co., Ltd. | |||||
| Net funds from acquisition of Goldfinch-Chong (Fuzhou) Technology Co., Ltd. | |||||
| Net funds from acquisition of SolanAI Global Ltd. HK | |||||
| Net Cash Provided by Investing Activities | |||||
| Cash Flows from Financing Activities: | |||||
| Proceeds from convertible note payable | |||||
| Proceeds from loans | |||||
| Repayment of loans | |||||
| Advancement from related party | |||||
| Proceeds from loan payable - related party | |||||
| Repayments of loan payable – related party | |||||
| Repayment of loan payable - related party | |||||
| Net Cash Provided by Financing Activities | |||||
| Cash at beginning of period | |||||
| Effect of exchange rate changes on cash | |||||
| Net Change in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents, beginning of period | |||||
| Cash and Cash Equivalents, end of period | |||||
| Cash consists of: | |||||
| Cash | |||||
| Cash at bank | |||||
| Funds held in trust | |||||
| Closing cash | |||||
| Supplemental Disclosure Information: | |||||
| Cash paid for interest | |||||
| Cash paid for taxes | |||||
| Cash paid for taxes | |||||
| Non-Cash Disclosure: | |||||
| Foregivness of loan payable to related party | |||||
| Forgiveness of loan payable to related party | |||||
| Issuance of common stock as commitment shares | |||||
| Issuance of common stock to non-affiliates for services | |||||
| Issuance of common stock to related party for services | |||||
| Issuance of common stock for debt settlement | |||||
| Stock payable for debt settlement | |||||
| Conversion of convertible notes payable | |||||
| Issuance of common stock for acquisition of Goldfinch Group Holdings Ltd. BVI | |||||
| Issuance of common stock for acquisition of SolanAI Global Ltd. | |||||
| Issuance of common stock for acquisition of Xirangsheng (Shenzhen) Health Technology Co., Ltd. | |||||
Loading...